Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-12,110
Closed -$731K 275
2018
Q1
$731K Buy
+12,110
New +$690K 0.02% 323
2016
Q1
Sell
-195,000
Closed -$7.67M 281
2015
Q4
$7.67M Buy
195,000
+6,900
+4% +$276K 0.24% 98
2015
Q3
$7.14M Buy
188,100
+7,600
+4% +$321K 0.21% 98
2015
Q2
$7.17M Sell
180,500
-13,300
-7% -$414K 0.21% 100
2015
Q1
$5.19M Buy
+193,800
New +$5.47M 0.15% 149

Other funds holding AMED

Hennessy Advisors Inc's AMED Position: Q2 2018 in Review

Hennessy Advisors Inc sold out of Amedisys (AMED) in Q2 2018, closing a stake of 12,110 shares — an estimated $731K sold.

Hennessy Advisors Inc first reported a position in AMED in Q1 2015 and held it in 5 quarters. The position peaked at $7.67M in Q4 2015. 216 funds tracked by Wall St. Rank hold AMED as of Q2 2018.

  • Hennessy Advisors Inc reported no remaining Amedisys position as of Q2 2018 after selling out during the quarter.
  • Hennessy Advisors Inc sold 12,110 Amedisys shares in Q2 2018, an estimated $731K.
  • Hennessy Advisors Inc first reported a position in Amedisys in Q1 2015 and held it in 5 quarters.
  • Hennessy Advisors Inc's Amedisys position peaked at $7.67M in Q4 2015.
  • 216 funds tracked by Wall St. Rank held Amedisys as of Q2 2018.

Based on Hennessy Advisors Inc's 13F filing for Q2 2018, filed 20 Jul 2018.